Merus (MRUS) director Haddock received 17,688 Share Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Jason Haddock (director at Merus N.V., MRUS) reported that they received 17,688 Share Option (right to buy) on May 7, 2024.
- Reporting person
- Haddock Jason
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 7, 2024 | Grant or award (A) | Share Option (right to buy)On 17,688 Common Shares1 | +17,688 | - | - | 17,688 direct |
Holdings before and after
- Share Option (right to buy): 0 to 17,688 direct
Footnotes from the filing
- 1. Options vest over a three-year period commencing May 7, 2024. One-third vest after one year and in 24 equal monthly installments thereafter.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Haddock report in this MRUS Form 4?
Jason Haddock (director at Merus N.V., MRUS) reported that they received 17,688 Share Option (right to buy) on May 7, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for MRUS
Earlier insider filings at MRUS
- May 9, 2024SEC Form 4 filed by Pucci Paolo
- May 9, 2024SEC Form 4 filed by Liu Hui
- May 9, 2024SEC Form 4 filed by Lundberg Sven Ante
- May 9, 2024SEC Form 4 filed by Silverman Peter B.
- May 9, 2024SEC Form 4 filed by Perry Gregory D
Quantisnow market dataNASDAQ
MRUS
Merus N.V.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Get push alerts for MRUS
Full MRUS profile on Quantisnow Follow MRUS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time